A Randomised, Double-blind, Placebo-controlled, Dose Ascending, 3-way Crossover Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers.

Trial Profile

A Randomised, Double-blind, Placebo-controlled, Dose Ascending, 3-way Crossover Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jun 2017

At a glance

  • Drugs GSK 870086 (Primary)
  • Indications Asthma
  • Focus Pharmacokinetics
  • Acronyms SIG
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 19 Nov 2010 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
    • 19 Nov 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top